会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
    • 非核苷酸逆转录酶抑制剂
    • WO02076982A3
    • 2002-12-12
    • PCT/CA0200385
    • 2002-03-21
    • BOEHRINGER INGELHEIM CA LTDOGILVIE WILLIAM WDEZIEL ROBERTNAUD JULIEO'MEARA JEFFREY
    • OGILVIE WILLIAM WDEZIEL ROBERTNAUD JULIEO'MEARA JEFFREY
    • A61K31/551A61P31/14A61P31/18A61P43/00C07D471/14A61K31/55
    • C07D471/14
    • A compound of formula (I) wherein A is a connecting chain of (C1-3) alkyl; B is O or S; R is H, (C1-6) alkyl, halo, CF3, or OR wherein R is H or (C1-6)alkyl; R is H or Me; R is H or Me; R is H, (C1-4) alkyl, (C3-4) cycloalkyl and (C1-4)alkyl(C3-7)cycloalkyl; W is selected form formula (i), (ii) or (iii) wherein, a) one of Y is SO2 and the other Y is NR , provided that both are not the same, wherein R is H, (C1-6)alkyl,(C3-6) cycloalkyl, the alkyl being substituted, COR , COOR or CONR R ; and each R is H, (C1-4) alkyl, (C3-6) cycloalkyl, or (C1-4) alkyl-(C3-6) cycloalkyl; or b) E is CR R wherein R and R is H, or alkyl and J is CH2; or J is CR R and E is CH2, and the dotted line represents a single bond; or c) E is C(O) and J is CR R or J is C(O) and E is CR R and the dotted line represents a single bond; or d) E and J are CR R and the dotted line represents a double bond. Compounds of formula I have activity against HIV WT and double mutant strains.
    • 式(I)的化合物,其中A是(C 1-3)烷基的连接链; B是O或S; R 1是H,(C 1-6)烷基,卤素,CF 3或OR 1a,其中R 1a是H或(C 1-6)烷基; R 2是H或Me; R 3是H或Me; R 4是H,(C 1-4)烷基,(C 3-8)环烷基和(C 1-4)烷基(C 3-7)环烷基; W选自式(i),(ii)或(iii),其中a)Y中的一个是SO 2,另一个Y是NR 5,条件是两者不同,其中R 5是H ,(C 1-6)烷基,(C 3-6)环烷基,取代的烷基,COR 50,COOR 5或CONR 5 R 5; 并且每个R 8是H,(C 1-4)烷基,(C 3-6)环烷基或(C 1-4)烷基 - (C 3-6)环烷基; 或b)E是CR 8a R 8b,其中R 8a和R 8b是H,或烷基,J是CH 2; 或J为CR 8a R 8b且E为CH 2,虚线表示单键; 或c)E是C(O),J是CR 8a R 8b或J是C(O),E是CR 8a R 8b,虚线代表单键; 或d)E和J是CR 8a R 8b,虚线表示双键。 式I化合物具有抗HIV WT和双突变株的活性。